Catheter Precision Inc [VTAK] stock prices are down -25.65% to $3.16 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The VTAK shares have lost -3.86% over the last week, with a monthly amount drifted -30.12%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Catheter Precision Inc [AMEX: VTAK] stock has seen the most recent analyst activity on August 13, 2019, when Piper Jaffray downgraded its rating to a Neutral and also revised its price target to $1.50 from $9. Previously, Maxim Group started tracking the stock with Buy rating on November 02, 2018, and set its price target to $23.
The stock price of Catheter Precision Inc [VTAK] has been fluctuating between $2.49 and $47.31 over the past year. Catheter Precision Inc [AMEX: VTAK] shares were valued at $3.16 at the most recent close of the market.
Analyzing the VTAK fundamentals
The Catheter Precision Inc [AMEX:VTAK] reported sales of 0.60M for trailing twelve months, representing a surge of 127.96%. Gross Profit Margin for this corporation currently stands at 0.92% with Operating Profit Margin at -23.58%, Pretax Profit Margin comes in at -29.64%, and Net Profit Margin reading is -31.5%. To continue investigating profitability, this company’s Return on Assets is posted at -0.74, Equity is -1.92 and Total Capital is -0.68. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.44.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.05 points at the first support level, and at 2.95 for the second support level. However, for the 1st resistance point, the stock is sitting at 3.33, and for the 2nd resistance point, it is at 3.51.
Ratios To Look Out For
It’s worth pointing out that Catheter Precision Inc [AMEX:VTAK]’s Current Ratio is 0.44. Also, the Quick Ratio is 0.43, while the Cash Ratio stands at 0.18. Considering the valuation of this stock, the price to sales ratio is 6.47, the price to book ratio is 0.46.
Transactions by insiders
Recent insider trading involved COLOMBATTO MARTIN J, Director, that happened on Jan 29 ’25 when 3.0 shares were sold.
